Valued at $145.0M at its later-stage round, Oct 2025. Nothing has traded since.
- ·The complete investor list: 19 names
- ·Watch Affinia Therapeutics: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Affinia Therapeutics funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Early Stage VC | $13.3M | ▮ | ▮ |
| Apr 2021 | Later Stage VC | $110.0M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $38.5M | ▮ | ▮ |
Membership and data by Private Market View
Affinia Therapeutics valuation
Affinia Therapeutics was valued at $145 million at its later-stage round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Affinia Therapeutics raised?
Affinia Therapeutics has raised $210 million across 3 recorded rounds since 2020. The largest was a $38.5 million early-stage round in Mar 2020; the most recent was a $13.3 million early-stage round in Sep 2025.
Affinia Therapeutics has filed 2 Form Ds with the SEC since 2020, most recently in May 2021 ($110 million sold to 22 investors).
How Affinia Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Affinia Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Affinia Therapeutics
- What is Affinia Therapeutics worth?
- Affinia Therapeutics is valued at $145.0M as of Oct 2026. Valued at $145.0M at its later-stage round, Oct 2025. Nothing has traded since.
- How much has Affinia Therapeutics raised?
- Affinia Therapeutics has raised $210.0M in total funding across 3 recorded rounds.
- When did Affinia Therapeutics last raise?
- Affinia Therapeutics last raised in Sep 2025 (Early Stage VC), raising $13.3M.